This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Medtronic MiniMed, Inc.
Medtronic MiniMed, Inc., a subsidiary of Medtronic plc, is a leading innovator in diabetes management, headquartered in the United States. Founded in 1980, the company has made significant strides in the development of advanced insulin delivery systems and continuous glucose monitoring technologies. With a strong presence in North America and Europe, Medtronic MiniMed focuses on providing integrated diabetes care solutions that enhance patient outcomes. Its flagship products, including the MiniMed insulin pumps and Guardian continuous glucose monitoring systems, are renowned for their reliability and user-friendly design. Recognised for its commitment to improving the lives of those with diabetes, Medtronic MiniMed has established a prominent market position, continually pushing the boundaries of technology in the healthcare industry.
DitchCarbon Score
How does Medtronic MiniMed, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Medtronic MiniMed, Inc.'s score of 43 is higher than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Medtronic MiniMed, Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Medtronic plc, which influences its climate commitments and emissions reporting. As part of its parent company's sustainability initiatives, Medtronic plc has set various reduction targets and participates in industry-standard climate frameworks. However, specific reduction targets or achievements for Medtronic MiniMed, Inc. are not detailed in the available data. The emissions data and climate commitments are cascaded from Medtronic plc, which is responsible for the overarching sustainability strategy. Medtronic plc engages in initiatives such as the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), which guide its emissions reduction efforts. While Medtronic MiniMed, Inc. does not report its own emissions figures, it aligns with the broader corporate family’s climate strategies and commitments. In summary, while specific emissions data for Medtronic MiniMed, Inc. is not available, the company is part of a larger framework of climate commitments led by Medtronic plc, focusing on sustainability and emissions reduction across its operations.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 74,992,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 |
| Scope 2 | 269,008,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | 000,000,000 | 000,000,000 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Medtronic MiniMed, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
